| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3992467 | Journal of Thoracic Oncology | 2007 | 4 Pages |
Abstract
With this particular dose and schedule, pralatrexate as a single agent had no activity in malignant pleural mesothelioma.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Lee M. MD, Robert T. MD, Mark G. MD, Ennapadam PhD, F.M. PhD,